Skip to Content

93 7441 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint 93 7441 is Orange, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Teva Pharmaceuticals USA.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7441

Divalproex Sodium Delayed-Release

Imprint
93 7441
Strength
500 mg
Color
Orange
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7441
Inactive Ingredients
hypromellose 2910 (6 mPa.s), hypromellose phthalate (31% phthalate, 40 cst), ferrosoferric oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, polyethylene glycol 4000, povidone k30, corn starch, propylene glycol, shellac, silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate, ferric oxide red, ferric oxide yellow, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.